Rabesta Tablet 20 mg (Rabeprazole Sodium)

Adult dose

Gastric ulcer, duodenal ulcer: 10 mg administered orally once daily, which may be increased to 20 mg once daily depending on symptoms. Administer for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: 10 mg or 20 mg administered orally once daily for 4 to 8 weeks. If symptoms persist after 8 weeks, an additional course of 10 mg or 20 mg twice daily for 8 weeks may be prescribed.

This medication should not be used in patients with known allergies to specific ingredients or a history of hypersensitivity reactions. Additionally, it is contraindicated for patients taking certain antibiotics or other medications, as well as pregnant or nursing women. Patients with impaired liver function, the elderly, and those with a history of drug allergies should use this medication with caution. This drug may cause hypersensitivity reactions such as skin rash, itching, or hives, and should be discontinued if symptoms occur. Regular blood tests and liver function tests should be conducted, and any unusual symptoms should be reported to healthcare providers immediately. Adverse reactions may occur in various systems including cardiac, gastrointestinal, neurological, respiratory, and skin, so monitoring for symptoms is important. Long-term use of this medication may increase the risk of osteoporosis and fractures, so caution is necessary. Additionally, prolonged use may lower blood magnesium levels, requiring regular testing and supplementation if necessary. This medication suppresses gastric acid secretion, which may increase the risk of certain bacterial infections, and patients should seek immediate diagnosis and treatment if symptoms such as diarrhea persist. Care should be taken when driving or operating machinery as drowsiness may occur. Interactions with other medications may take place, so patients should inform healthcare providers of any medications they are taking. It is safest to avoid this medication during pregnancy or nursing. The safety in children has not been established, and it should not be used in this population. In the event of overdose, there is no specific antidote, so immediate consultation with healthcare providers is required for treatment based on symptoms. This medication should be swallowed whole without chewing or crushing, and kept out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in oral/eye mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), severe lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, difficulty urinating

Mild side effects

• Rash
• itching
• decreased red blood cells
• decreased white blood cells
• increased white blood cells
• increased eosinophils
• increased neutrophils
• decreased lymphocytes
• anemia
• petechiae

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's efficacy and safety for a long time.

Appearance

Pale yellow round enteric-coated tablet

Package unit

56 tablets/box [(14 tablets/PTP) × 4]